Brandinium

Trademark search for:

IMPEDEVIR

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 1999-04-12 — Application filed
  • 1999-04-12 — Sec. 1(b) claim added
  • 1999-08-16 — Assigned to examiner
  • 1999-08-20 — Letter of suspension mailed
  • 1999-09-22 — Correspondence received in law office
  • 1999-11-02 — Examiner's amendment mailed
  • 1999-11-10 — Approved for pub - principal register
  • 2000-02-04 — Notice of publication
  • 2000-03-07 — Published for opposition
  • 2000-05-30 — Noa mailed - sou required from applicant
  • 2000-11-30 — Sou extension 1 filed
  • 2001-03-30 — Application abandoned
  • 2001-05-07 — Sou extension 1 granted
  • 2001-05-08 — Sou extension 2 filed
  • 2001-05-17 — Petition to revive-received
  • 2001-11-07 — Sou extension 2 granted
  • 2001-11-08 — Sou extension 3 filed
  • 2002-04-23 — Petition to revive-granted
  • 2002-05-01 — Sou extension 3 granted
  • 2002-05-30 — Sou extension 4 filed
  • 2002-06-08 — Sou extension 4 granted
  • 2002-11-19 — Sou teas extension received
  • 2002-11-19 — Sou extension 5 filed
  • 2003-01-02 — Sou extension 5 granted
  • 2003-05-31 — Final status recorded
  • 2003-09-22 — Application abandoned

Owner Information

Glaxo Group Limited
Middlesex UB6 ONN GB
Glaxo Group Limited
Middlesex UB6 ONN GB

Correspondent

SHELDON R PONTAOE GLAXOSMITHKLINE
CORPORATE INTELLECTUAL PROPERTY - MAI-B4
FIVE MOORE DR
RESEARCH TRIANGLE PARK, NC 27709

Filing Details

Filing Date:
1999-04-12
Status Date:
2003-05-31
Category:
Pharmaceuticals
Filing Year:
1999

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.